Navigation Links
Thomson Reuters Joins the InChI Trust
Date:8/18/2009

PHILADELPHIA and LONDON, Aug. 18 /PRNewswire/ --Thomson Reuters today announced that they have joined the InChI Trust, a not-for-profit organization to expand and develop the InChI Open Source chemical structure representation algorithm. The algorithm provides a consistent, credible and compatible way for databases of chemical structures to be linked together for the benefit of users of chemical information around the world.

"We are committed to supporting the InChI Trust and InChI initiative," said Dr. Josep Prous, Jr., Vice President and Chief Scientific Officer at Thomson Reuters. "The latest version of Prous Science Integrity(R) drug discovery database adds InChI's and InChIKeys to the more than 370,000 drugs and intermediates covered, facilitating access to and communication of information in the chemistry community."

Support of the InChI initiative and the adoption of InChI's within Prous Science Integrity(R) will further chemistry users' ability to integrate information across multiple sources and communicate this information in a consistent way across the globe.

"We are delighted to welcome Thomson Reuters as a member of the InChI Trust," says Project Leader Dr. Stephen Heller. "We value their support, as specialists within the chemical information industry, to continue to develop the InChI and InChIKey standards to enable wide scale linking of chemical information."

Prous Science Integrity seamlessly integrates biological, chemical and pharmacological information on more than 300,000 compounds with demonstrated biological activity, plus tens of thousands of synthesis intermediates and over 125,000 patent family records. Updated daily, this unique database is designed to empower your drug discovery and development activities. Find out more about Prous Science Integrity here.

Thomson Reuters will be attending the 238(th) American Chemical Society's National Meeting and Exposition, August 16-20, 2009 in Washington, DC and ChemOutsourcing, September 14-16, 2009 in Long Branch, NJ. Researchers are encouraged to come and receive a demonstration of the latest changes to Prous Science Integrity.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
2. Thomson Reuters Partners With Sagient Research
3. Brazils Scientific Research On The Rise, Thomson Reuters Study Finds
4. Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available
5. Thomson Reuters Examines Highly Cited Research in Bioterrorism
6. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
7. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
8. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
9. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
10. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
11. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
Breaking Biology Technology:
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):